Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 17:11:3327-3337.
doi: 10.2147/CMAR.S197911. eCollection 2019.

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

Shuo Li  1   2   3   4 , Huaxiang Xu  1   2   3   4 , Wenquan Wang  1   2   3   4 , Heli Gao  1   2   3   4 , Hao Li  1   2   3   4 , Shirong Zhang  1   2   3   4 , Jinzhi Xu  1   2   3   4 , Wuhu Zhang  1   2   3   4 , Shuaishuai Xu  1   2   3   4 , Tianjiao Li  1   2   3   4 , Quanxing Ni  1   2   3   4 , Xianjun Yu  1   2   3   4 , Chuntao Wu  1   2   3   4 , Liang Liu  1   2   3   4
Affiliations

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

Shuo Li et al. Cancer Manag Res. .

Abstract

Purpose: The systemic inflammation response index (SIRI), based on peripheral neutrophil, monocyte, and lymphocyte counts, was recently emerged and used as a novel tool in predicting prognosis in different types of cancer. Our aim was to investigate the clinical significance of preoperative SIRI in patients with resectable pancreatic ductal adenocarcinoma (PDAC). Materials and methods: The SIRI was developed in a training cohort of 371 PDAC patients undergoing radical surgery between 2010 and 2013 and validated in a validation cohort of 310 patients from 2014 to 2015. Baseline clinicopathologic characteristics, preoperative laboratory parameters and follow-up information were collected. The optimal cutoff value of SIRI was determined by receiver operating characteristic curve. Univariate and multivariate analysis were performed to analyze the prognostic value of SIRI. Results: The optimal cutoff value of SIRI stratified patients into low SIRI group (≤0.69) and high SIRI group (>0.69). Survival analysis showed that the median overall survival (OS) and recurrence-free survival (RFS) were significantly better in patients with low SIRI. The SIRI was an independent predictor of OS and RFS in multivariate analysis. In addition, SIRI remained its prognostic significance both in patients with early-stage diseases and in patients with normal carbohydrate antigen 19-9 levels. High SIRI indicated poor treatment response for patients who received postoperative adjuvant chemotherapy. Conclusion: Preoperative SIRI was an independent prognostic indicator of poor outcomes in PDAC patients after radical resection. It might assist clinicians to identify high-risk patients and choose the optimal individualized treatment strategy.

Keywords: overall survival; pancreatic ductal adenocarcinoma; prognosis; recurrence-free survival; systemic inflammation response index.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Prognostic significance of SIRI in PDAC patients undergoing radical surgery. Kaplan‒Meier survival curves of OS and RFS stratified by SIRI in the training cohort (A, B) and validation cohort (C, D). Abbreviations: SIRI, systemic inflammation response index; PDAC, pancreatic ductal adenocarcinoma; OS, overall survival; RFS, recurrence-free survival.
Figure 2
Figure 2
Prognostic significance of SIRI in PDAC patients with normal CA19-9 and early-stage diseases in the training cohort. Kaplan‒Meier survival curves of OS and RFS stratified by SIRI in normal CA19-9 subgroups (A, B) and early-stage subgroups (C, D). Abbreviations: SIRI, systemic inflammation response index; PDAC, pancreatic ductal adenocarcinoma; CA19-9, carbohydrate antigen 19-9; OS, overall survival; RFS, recurrence-free survival.
Figure 3
Figure 3
Prognostic significance of SIRI in PDAC patients with normal CA19-9 and early-stage diseases in the validation cohort. Kaplan‒Meier survival curves of OS and RFS stratified by SIRI in normal CA19-9 subgroups (A, B) and early-stage subgroups (C, D). Abbreviations: SIRI, systemic inflammation response index; PDAC, pancreatic ductal adenocarcinoma; CA19-9, carbohydrate antigen 19-9; OS, overall survival; RFS, recurrence-free survival.
Figure 4
Figure 4
Prognostic significance of SIRI in PDAC patients who received postoperative adjuvant chemotherapy. Kaplan-‒Meier survival curves of OS and RFS stratified by SIRI in the training cohort (A, B) and validation cohort (C,). Abbreviations: SIRI, systemic inflammation response index; PDAC, pancreatic ductal adenocarcinoma; OS, overall survival; RFS, recurrence-free survival.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442 - DOI - PubMed
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338 - DOI - PubMed
    1. Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet (London, England). 2016;388(10039):73–85. doi:10.1016/S0140-6736(16)00141-0 - DOI - PubMed
    1. Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596. doi:10.1038/nrclinonc.2015.105 - DOI - PubMed
    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013 - DOI - PubMed